Zobrazeno 1 - 10
of 28
pro vyhledávání: ''
Publikováno v:
Lung Cancer. 136:37-44
Purpose The purpose of this study was to elucidate the clinicopathologic and lymph node metastatic characteristics in patients with adenocarcinoma manifested as persistent ground glass mass (GGM, ground glass opacity [GGO] exceeding 3 cm in diameter)
Publikováno v:
Lung Cancer. 126:201-207
Objectives In case of inoperability or refusal of surgery, stereotactic body radiation therapy (SBRT) is the most effective treatment for a stage I non-small cell lung carcinoma (NSCLC). The results obtained by this irradiation technique are consider
Autor:
H. Henry Guo, Christian A. Kunder, Joel W. Neal, Samantha X Y Wang, Li Lei, Joseph B. Shrager
Publikováno v:
Lung Cancer. 122:187-191
When a patient is found to have multiple lung tumors, distinguishing whether they represent metastatic nodules or separate primary cancers is crucial for staging and therapy. We report the case of a 79-year-old patient with two surgically resected sy
Publikováno v:
Lung Cancer. 122:1-6
Background Avitinib is an oral, potent, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor selective for the EGFR T790 M mutation. We report the safety, intra-/extracranial efficacy, and the blood–brain barrier (BBB) pen
Autor:
Raúl M. Luque, Leo J. Hofland, Aura D. Herrera-Martínez, Ángel Salvatierra, María A Gálvez-Moreno, Manuel D. Gahete, Rafael Sánchez-Sánchez, Raquel Serrano-Blanch, Justo P. Castaño, Rosa Ortega Salas
Publikováno v:
Lung Cancer, 109, 128-136. Elsevier Ireland Ltd
Background Lung carcinoids (LCs) are rare tumors that comprise 1–5% of lung malignancies but represent 20–30% of neuroendocrine tumors. Their incidence is progressively increasing and a better characterization of these tumors is required. Alterat
Autor:
Rozemarijn Vliegenthart, Carlijn M. van der Aalst, Harry J.M. Groen, Kristiaan Nackaerts, Geertruida H. de Bock, Robin B. Peters, Joan Walter, Uraujh Yousaf-Khan, Peter M. A. van Ooijen, Harry J. de Koning, Matthijs Oudkerk, Marjolein A Heuvelmans
Publikováno v:
Lung Cancer, 113, 45-50. Elsevier Ireland Ltd
Lung Cancer, 113, 45-50. ELSEVIER IRELAND LTD
Lung Cancer, 113, 45-50. ELSEVIER IRELAND LTD
Objectives: To explore the relationship between nodule count and lung cancer probability in baseline low-dose CT lung cancer screening.Materials and Methods: Included were participants from the NELSON trial with at least one baseline nodule (3392 par
Autor:
W. Torre, Jorge M. Núñez-Córdoba, Gorka Bastarrika, Pablo Sanchez-Salcedo, Maria D. Lozano, Arantza Campo, Juan P. de-Torres, Ana B. Alcaide, María José García-Velloso, Javier J. Zulueta, Lidia Sancho, José A. Richter
Publikováno v:
Lung Cancer. 97:81-86
Background A major drawback of lung cancer screening programs is the high frequency of false-positive findings on computed tomography (CT). We investigated the accuracy of selective 2-[fluorine-18]-fluoro-2-deoxy- d -glucose (FDG) Positron Emission T
Autor:
Shingo Matsumoto, Tatsuya Yoshida, Yuichiro Ohe, Hironobu Ohmatsu, Kiyotaka Yoh, Shigeki Umemura, Koichi Goto, Seiji Niho
Publikováno v:
Lung Cancer. 90:477-483
Background Progression patterns at the response evaluation criteria in solid tumors-progressive disease (RECIST-PD) during treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for advanced non-small cell lung cancer
Autor:
Takayuki Fukui, Koji Kawaguchi, Koichi Fukumoto, Kohei Yokoi, Akihiro Hirakawa, Shota Nakamura
Publikováno v:
Lung Cancer. 89:38-42
Introduction Recent studies have demonstrated that ground glass opacity (GGO)-dominant tumors correspond to pathologically low-grade adenocarcinomas and that patients with resected tumors have an excellent prognosis. However, almost all of those stud
Autor:
Naohiro Kajiwara, Masaru Hagiwara, Sachio Maehara, Yasufumi Kato, Tatsuo Ohira, Koichi Yoshida, Yoshihisa Shimada, Hisashi Saji, Norihiko Ikeda, Keishi Otani, Masatoshi Kakihana, Soichi Akata, Junichi Maeda
Publikováno v:
Lung Cancer. 88:174-180
Objectives We reviewed the medical record of a series of patients with synchronous multiple lung cancers (SMLC), in an attempt to identify the optimal treatment strategy for multiple ground-glass opacities (GGOs). Materials and methods From 2004 to 2